# Xpert Bladder Monitor: a Non-Invasive Follow-Up Tool for Detecting Relapse in High Grade or High Risk Bladder Cancer

> **NCT06751667** · NA · NOT_YET_RECRUITING · sponsor: **Fondazione IRCCS Istituto Nazionale dei Tumori, Milano** · enrollment: 50 (estimated)

## Conditions studied

- Bladder (Urothelial, Transitional Cell) Cancer
- Bladder Cancer
- Bladder Tumors
- Bladder Cancer Recurrence
- Cystoscopy

## Interventions

- **DEVICE:** Urinary biomarkers

## Key facts

- **NCT ID:** NCT06751667
- **Lead sponsor:** Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2032-01-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06751667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06751667, "Xpert Bladder Monitor: a Non-Invasive Follow-Up Tool for Detecting Relapse in High Grade or High Risk Bladder Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06751667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
